Madavaraju K, Yadavalli T, Singh SK, Qatanani F, et al. Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection. Antiviral Res 2021;194:105145.
PMID: 34303747